ESMO 2014 Report: Proton beam therapy: Emperor’s new clothes
by Denis Wheatley: In her introduction, Yolane Lievens (Belgium) explained that when we have to defer from making comment because of the need to be discrete (the Emperor… read more.
by Denis Wheatley: In her introduction, Yolane Lievens (Belgium) explained that when we have to defer from making comment because of the need to be discrete (the Emperor… read more.
Keynote lecture: Professor Sir Mike Stratton (Cambridge/Hinxton, UK) by Denys Wheatley. On the thesis that the genetic understanding of cancer is fundamental to classifying and hence treating patients… read more.
Click ‘Read More’ for the new data delegate views on whether early tumour shrinkage is now an accepted marker in mCRC.
by Denys Wheatley: Chaired by Atsushi Ohtsu and Jean-Yves Douillard, the first speaker Dr Kato (Japan) addressed the issue of the quest for different mutations in the hope… read more.
by Denys Wheatley: A large cohort study of Regorafenib (REG) in the real-life setting in patients previously treated for metastatic colorectal cancer
by Denys Wheatley: The session dealt primarily with the advanced (stage 2 and 3) colon cancer patients who had undergone resection, in a study discussed by Thiery Andre… read more.
Reports from the European Society for Medical Oncology 2014 Congress in Madrid by Denys Wheatley: In his talk on Visualising the true spectrum of cancer- will we get… read more.
Ger Walpole, CNS (Clinical Nurse Specialist), H.Dip Oncology Nursing, BNS(Hons), Sligo Regional Hospital, Sligo. Dr Andrew Hodgson, MB, BS, BSc (Hons), FRCPI, FFPath, FRCPath. Written by Karen Mas-Mollinedo… read more.
by Bruce Sylvester: Researchers report that 90% of subjects with acute lymphoblastic leukemia (ALL) who had relapsed multiple times or failed to respond to standard therapies have achieved… read more.
Advertisment